HERCULES CAPITAL INC
HTGC · NYSE
Updated at 2026-10-14 10:07:00
- Today's High
- $16.67
- Today’s Low
- $16.36
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $16.55
- Previous Close
- $16.54
- Volume
- 758.56K
- Market Cap
- $3.09B
- P/E Ratio
- 8.06X
- EPS
- $1.94
Previous Day Range
52-Week Range
Company Overview
- Sector
- FINANCIAL SERVICES
- Industry
- Financial Services
- Sub-industry
- ASSET MANAGEMENT
- Headquarters
- 1 NORTH B STREET, SAN MATEO, CA, UNITED STATES, 94401
- Country
- US
- Listing Date
- 2005-06-09
- Fiscal Year End
- December
- Shares Outstanding
- 187.12M
- CIK
- 0001280784
- Website
- www.htgc.com
Hercules Capital, Inc. (HTGC) is a leading publicly traded business development company that specializes in providing tailored debt and equity financing solutions to growth-oriented companies, primarily in the technology and life sciences sectors. Leveraging its deep industry knowledge and expertise, Hercules focuses on investing in high-growth firms, facilitating their scalability while ensuring a diversified portfolio that prioritizes credit quality and risk-adjusted returns. As a strategic partner for innovative ventures, Hercules Capital is dedicated to fostering sustainable value, making it an attractive investment opportunity for institutional investors seeking exposure to dynamic and emerging markets.
Financial Metrics
Revenue
2026-06-30
$156.81M
2026-03-31
$95.92M
2025-12-31
$157.74M
2025-09-30
$169.31M
Operating Expenses
2026-06-30
-$4.67M
2026-03-31
$25.28M
2025-12-31
$38.47M
2025-09-30
$25.43M
Net Income
2026-06-30
$130.18M
2026-03-31
$42.5M
2025-12-31
$90.82M
2025-09-30
$119.68M
Net Profit Margin
2026-06-30
83.01%
2026-03-31
44.3%
2025-12-31
57.57%
2025-09-30
70.68%
Earnings Per Share
2026-06-30
$0.50
2026-03-31
$0.48
2025-12-31
$0.48
2025-09-30
$0.49
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$158.39M
2026-03-31
$42.58M
2025-12-31
$116.27M
2025-09-30
$119.76M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $156.81M | $95.92M | $157.74M | $169.31M |
| Operating Expenses | -$4.67M | $25.28M | $38.47M | $25.43M |
| Net Income | $130.18M | $42.5M | $90.82M | $119.68M |
| Net Profit Margin | 83.01% | 44.3% | 57.57% | 70.68% |
| Earnings Per Share | $0.50 | $0.48 | $0.48 | $0.49 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $158.39M | $42.58M | $116.27M | $119.76M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.